Expression and clinical significance of ATM and PUMA gene in patients with colorectal cancer

The expression of ataxia-telangiectasia mutated (ATM) and p53 upregulated modulator of apoptosis (PUMA) genes in patients with colorectal cancer were investigated, to explore the correlation between the expression of ATM and PUMA and tumor development, to evaluate the clinical significance of ATM and PUMA in the treatment of colorectal cancer. Quantitative real-time PCR was used to detect the expression of ATM and PUMA in tumor tissue and adjacent healthy tissue of 67 patients with colorectal cancer and in normal colorectal tissue of 33 patients with colorectal polyps at mRNA level. The expression level of ATM mRNA in colorectal cancer tissues was significantly higher than that in normal mucosa tissues and adjacent non-cancerous tissue (P≤0.05), while no significant differences in expression level of ATM mRNA were found between normal mucosa tissues and adjacent noncancerous tissue (P=0.07). There was a negative correlation between the expression of ATM mRNA and the degree of differentiation of colorectal cancer (r= −0.312, P=0.013), while expression level of ATM mRNA was not significantly correlated with the age, sex, tumor invasion, lymph node metastasis or clinical stage (P>0.05). Expression levels of PUMA mRNA in colorectal cancer tissues, adjacent noncancerous tissue and normal tissues were 0.68±0.07, 0.88±0.04 and 1.76±0.06, respectively. Expression level of PUMA mRNA in colorectal cancer tissues and adjacent noncancerous tissue was significantly lower than that in normal colorectal tissues (P<0.05). The results showed that ATM mRNA is expressed abnormally in colorectal cancer tissues. Expression of PUMA gene in colorectal carcinoma is downregulated, and is negatively correlated with the occurrence of cancer.

[1]  Liang Xie,et al.  Ataxia-Telangiectasia Mutated (ATM) Protein Signaling Participates in Development of Pulmonary Arterial Hypertension in Rats , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[2]  Jian Sun,et al.  miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma , 2017, Oncotarget.

[3]  Yunpeng Liu,et al.  Silencing β-linked N-acetylglucosamine transferase induces apoptosis in human gastric cancer cells through PUMA and caspase-3 pathways. , 2015, Oncology reports.

[4]  Ji-Min Chen,et al.  Caffeine Suppresses Apoptosis of Bladder Cancer RT4 Cells in Response to Ionizing Radiation by Inhibiting Ataxia Telangiectasia Mutated-Chk2-p53 Axis , 2015, Chinese medical journal.

[5]  Q. Hu,et al.  Effect of capilliposide for induction apoptosis in human nasopharyngeal cancer CNE-2 cells through up-regulating PUMA expression. , 2015, Journal of cancer research and therapeutics.

[6]  J. Siegfried,et al.  Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma , 2015, BMC Cancer.

[7]  A. Gerger,et al.  Genetic markers of recurrence in colorectal cancer. , 2015, Pharmacogenomics.

[8]  P. Mehdipour,et al.  Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory , 2015, Molecular Neurobiology.

[9]  P. Delrio,et al.  Genetics, diagnosis and management of colorectal cancer (Review) , 2015, Oncology reports.

[10]  Dandan Song,et al.  PUMA-mediated mitochondrial apoptotic disruption by hypoxic postconditioning , 2015, Apoptosis.

[11]  T. Stracker,et al.  ATM regulation of IL-8 links oxidative stress to cancer cell migration and invasion , 2015, eLife.

[12]  Bin Zhou,et al.  PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer , 2015, Oncotarget.

[13]  M. Ge,et al.  Abnormal Expression of DNA Double-Strand Breaks Related Genes, ATM and GammaH2AX, in Thyroid Carcinoma , 2015, International journal of endocrinology.

[14]  T. Conrads,et al.  Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells. , 2015, Gynecologic oncology.

[15]  S. Duensing,et al.  Harnessing the p53-PUMA Axis to Overcome DNA Damage Resistance in Renal Cell Carcinoma , 2014, Neoplasia.

[16]  Jing Gao,et al.  Downregulated Ku70 and ATM associated to poor prognosis in colorectal cancer among Chinese patients , 2014, OncoTargets and therapy.

[17]  Jian Yu,et al.  Abstract 667: Regorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis , 2015 .

[18]  Ratnesh K Singh,et al.  Frequent Alterations of MCPH1 and ATM are Associated with Primary Breast Carcinoma: Clinical and Prognostic Implications , 2013, Annals of Surgical Oncology.

[19]  T. He,et al.  Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells , 2013, International journal of oncology.

[20]  C. Dai,et al.  Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma. , 2015, European review for medical and pharmacological sciences.